Keyphrases
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Maintenance Chemotherapy
100%
Maintenance Therapy
66%
Progression-free Survival
50%
Consolidation Therapy
50%
Response Rate
16%
Initial Treatment
16%
Patient Outcomes
16%
Overall Survival
16%
Survival Benefit
16%
Patient Demographics
16%
Clinical Practice
16%
Advanced Stage
16%
Conventional Chemotherapy
16%
Consolidation Chemotherapy
16%
Randomized Clinical Trial
16%
Median Survival
16%
Treatment Toxicity
16%
Same Patient
16%
Quality of Life Improvement
16%
Therapeutic Challenges
16%
Prolonged Therapy
16%
Disease Control
16%
Nursing and Health Professions
Lung Cancer
100%
Maintenance Chemotherapy
100%
Progression Free Survival
50%
Maintenance Therapy
50%
Overall Survival
16%
Patient Population
16%
Quality of Life
16%
Treatment Outcome
16%
Clinical Practice
16%
Disease Control
16%
Consolidation Chemotherapy
16%
Medicine and Dentistry
Lung Cancer
100%
Maintenance Chemotherapy
100%
Progression Free Survival
50%
Maintenance Therapy
50%
Overall Survival
16%
Quality of Life
16%
Patient Population
16%
Consolidation Chemotherapy
16%
Randomized Clinical Trial
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Lung Cancer
100%
Progression Free Survival
50%
Overall Survival
16%
Randomized Clinical Trial
16%
Diseases
16%